SILVER SPRING, Md.--(BUSINESS WIRE)--Nuvilex, Inc. (OTCQB:NVLX), an emerging biotechnology provider of cell and gene therapy solutions, reports the Chairman of its associate company, SG Austria, Dr. Walter Gunzburg, participated in multiple private meetings with leading Japanese biotech and pharmaceutical companies following the recent Annual Meeting of the Organisation for Oncology and Translational Research (OOTR), where he was a invited guest speaker.
